SIGN UP
LOG IN
C
CYCC
Cyclacel Pharma
0.28
0.05+21.62%After Hours: 0.2796 +0.0011 +0.40%19:41 04/25 EDT
OPEN/PREV CLOSE0.2340/0.2290
TODAY RANGE0.2263-0.3000
VOL3.74M
MARKET CAP57.74M
52 WEEK RANGE0.1706-4.000
AVG VOL (3M)345.24K
% TURNOVER1.81%
TURNOVER--
P/E (TTM)-0.1330
% RANGE31.57%
EPS(TTM)-2.0936
P/E(FORWARD)-0.1428
P/B-1.1349
BVPS-0.2454
DIVIDEND0.6000
P/S56.84
BETA--
DIV YIELD215.44%
FREE FLOAT MKT CAP3.51M
SHARES OUTSTANDING207.34M
NEXT EARNINGS05/12-05/16
FREE FLOAT12.60M
LOT SIZE1
EX-DIV DATE04/29/2025
News
Press Releases
Financial Reports
Profile
Benzinga·6h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Seeking Alpha·18h ago
Cyclacel Pharmaceuticals declares $0.15 dividend
TipRanks·04/03 03:54
Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development
Press release·04/02 22:20
Cyclacel Pharmaceuticals, Inc. (CYCC) Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
TipRanks·04/02 20:59
Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift
Seeking Alpha·04/02 20:24
Cyclacel Pharmaceuticals GAAP EPS of -$0.33
Dow Jones·04/02 20:07
*Cyclacel Pharmaceuticals 4Q Loss/Shr 33c >CYCC
Dow Jones·04/02 20:07
*Cyclacel Pharmaceuticals 4Q Loss $3.05M >CYCC
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.